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David Baulcombe was born in 
the Midlands of the UK into a 
non-scientifi c family. He studied 
botany as an undergraduate at 
Leeds University (BSc 1973) and 
started his own research group 
at the Plant Breeding Institute 
in Cambridge after his PhD in 
Edinburgh (1977) and spells as a 
postdoc in Montreal and Athens 
Georgia. He has been in the 
Sainsbury Laboratory in Norwich 
since 1988 where he is a senior 
research scientist. His research 
interests have spanned plant 
hormones, root nodule symbioses, 
disease resistance, virology 
and over the last ten years have 
focused on RNA silencing and 
epigenetics. David has served 
as President of the International 
Society of Plant Molecular Biology 
and his research has been 
recognised by various awards, 
including elections to the Royal 
Society and the US National 
Academy of Sciences (foreign 
associate). His current interests 
include a systems approach to 
understanding the role of short 
silencing RNA in regulatory 
networks.
What infl uenced your path into 
biology? A school teacher, Mr. 
Garner, in my primary school. He 
made school exciting because 
you never knew what was coming 
up next. It must be enormously 
rewarding for good teachers for 
them to know that they shape 
the lives of young people so 
profoundly.
How did you decide on your 
current research topics? Through 
a series of accidents. In the mid 
1980s someone asked me to 
make some DNA clones of plant 
viruses. It turned out to be more 
straightforward than what I was 
doing at the time and so I started 
to read about virology. I found 
out about all sorts of interesting 
virological phenomena — 
non- coding RNA molecules 
that induce lethal necrosis, 
for example, and an inducible virus immunity mechanism fi rst 
described in 1927 — and my 
appetite was whetted. For the 
next ten years or so my lab delved 
in what a colleague recently 
referred to as the salt mines of 
virology and, in the process, 
we picked up on some strange 
results that led us to the immunity 
mechanism. It turned out that it 
was an RNA-mediated mechanism 
based on RNA silencing or RNA 
interference as it is sometimes 
known. I suppose I hoped that 
the understanding of these 
phenomena would lead to the 
‘important question’.
How do you write a grant 
application to investigate a 
phenomenon that ‘does not 
make sense’? I did not have to. 
I have the good fortune to be 
generously funded by a charitable 
foundation with the instruction 
to ‘do good science’ and, 
consequently, I had the fl exibility 
to follow up on interesting new 
angles as they arose. I wish that 
more scientists had this privilege: 
it would give them freedom that 
they may not have now and would 
release reviewers and grant panel 
members so that they too could 
get on with their research. The 
absence of tenure in my current 
job helps to focus my mind 
because, every fi ve years, I have 
to justify the way that I have spent 
the funds available to me. If I fail 
to convince I would be looking 
for a postdoc job somewhere. 
Under these terms I think that past 
achievement is at least as good as 
a grant application as a predictor 
of future productivity.
So do you think that peer 
review is not effective? On the 
contrary — there should always 
be the opportunity for some 
peer reviewed grant applications 
and in scientifi c publishing it 
is an essential quality control. 
Of course it is not perfect. Bad 
papers do get through and 
good papers occasionally get 
rejected. When papers from my 
lab are rejected we normally take 
note of reviewers’ comments, 
modify the text and add new 
data if appropriate and resubmit 
elsewhere. I do not normally 
engage in an argument with the editors. I have been surprised, 
as an editor, to see vitriolic 
comments from authors in 
response to rejection letters. 
Perhaps journals should publish a 
special section labelled ‘rejected 
papers’ for the work of these 
objectionable individuals.
Has your work been affected 
by the resistance in Europe to 
genetically modifi ed crops? Not 
directly — most of the work we 
do is basic rather than applied. 
However, I can sympathise with 
the part of the anti-GM campaign 
in which the real target is 
industrialised agriculture. I have 
a feeling that, if we accounted 
for the full environmental and 
socioeconomic cost of industrial 
agriculture, we would end up 
with smaller and less intensively 
cultivated farms than we have at 
present – especially in Europe. 
Any reduction in yield could be 
partly offset, perhaps, by genetic 
enhancements introduced by 
modern breeding methods or by 
genetic manipulation of the crop 
plants. 
I also think the GM debate is 
useful, on balance, because it 
means that European society is 
thinking through the implications 
of a powerful new technology 
before it is widely introduced. 
Wouldn’t it have been a good 
thing if someone had done the 
same thing before the introduction 
of the motor car? But I do think 
that some of the objections to GM 
crops are overstated. In my own 
area, for example, it is frustrating 
to hear about virus diseases 
that could be addressed by RNA 
silencing in transgenic plants. I 
do not think there are plausible 
hazards from these plants but, at 
present and for the foreseeable 
future in Europe at least, they are 
not being grown. The use of GM 
to transfer plant genes between 
plants could also avoid some of 
the conjectured complications 
associated with the engineering of 
non-plant genes into plant crops.
So do you wish you worked on 
animals and could see your work 
used in medicine? Emphatically 
no. Plants are what we eat, and 
what we use to make our clothes, 
paper, housing and fuel; they fi x 
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Quick guide
Bonobos
Linda Vigilant
What is a bonobo? One of the 
last major mammal species to be 
formally identifi ed, the bonobo 
(Pan paniscus) is still much less 
familiar to people than its close 
relative the chimpanzee (Pan 
troglodytes). Chimpanzees and 
bonobos look much alike, and 
the bonobo was formerly termed 
the ‘pygmy chimpanzee’, but 
use of this misleading moniker 
is now discouraged. Physical 
differences between the two 
species include a more slender 
build and longer head hair for 
the bonobo, along with a suite 
of behavioral differences. Even 
before the formal description of 
the species in 1929, which was 
based upon skull morphology, 
the pioneering primate behavior 
researcher Robert Yerkes 
noted the unusually pleasant 
temperament of a particular 
‘chimpanzee’ — now known 
to be a bonobo — under his 
care. Scientists are still trying to 
understand how chimpanzees 
and bonobos turned out so 
differently despite living in 
apparently similar ecological 
environments.
How’s their social life? Like 
chimpanzees, bonobos in 
the wild live in groups or 
‘communities’ composed of 
multiple adult males and females 
and their offspring. In contrast 
to chimpanzees, bonobos 
appear much more egalitarian 
in their social interactions. Even 
though they leave their natal 
communities upon reaching 
maturity and settle in a new 
group, the females manage to 
form strong social bonds and 
exert social dominance over the 
males, an exceedingly unusual 
turn of events for primates. 
In practical terms this means 
that females have control over 
feeding resources, and face little 
retaliation for aggression directed 
towards males. Adult males 
retain strong bonds with their 
mothers, and one study of a wild 
group suggests that sons of high 
ranking mothers are particularly 
successful in the important matter 
of siring offspring. In keeping with 
their more peaceful reputation, 
bonobos have not been observed 
to engage in the cooperative 
hunting and consumption of 
monkeys so often enthusiastically 
practised by chimpanzees. 
While bonobo groups occupy 
specifi c territories, these can 
be highly overlapping and even 
matings across community 
lines have been reported, while 
aggressive patrolling of territory 
boundaries and fearful avoidance 
of neighbors is more typical for 
chimpanzees. 
The bonobo characteristic 
that invariably elicits attention 
is their seeming tendency to 
have sex all the time. Not only 
is the frequency of sexual 
behavior remarkable, but also 
the manner — pairings can 
include all imaginable age 
and sex combinations. This is 
attributed to the use of sex not 
just for reproduction, but as a 
fl exible social tool. Engaging 
in a copulatory bout can mark 
reconciliation, reduce tension, or 
elicit social or food benefi ts. 
Ulindi is the dominant  female in the 
bonobo group in the Wolfgang Koehler 
Primate Research Center at the Leipzig 
Zoo, where she is choosy about partici-
pating in psychology tests. (Photo: 
Michael Seres.)CO2 and stop the planet from 
frying up; and they underpin the 
ecosystems and biodiversity 
that are central to sustainability. 
Also, they are excellent model 
organisms for fundamental 
processes in biology: vide 
Hooke, who discovered cells in 
cork in the seventeenth century; 
Mendel and genetics in peas; van 
Beijerinck who fi rst described 
viruses in tobacco; McClintock 
and mobile genetic elements 
in maize; and many others. 
How could I want to work on 
anything else? Modern botany 
contributes both to medicine and 
environmental science.
What would you be if you were 
not a biologist? Probably an 
economist. I am concerned 
about the sustainability of current 
economic models that are 
dependent on growth and in which 
the currency is money rather than 
well-being and quality of life. Even 
in this other life, however, I might 
well fi nd myself looking at cells 
and ecosystems as examples of 
complex, self-correcting systems 
that could be used as models for 
a new economics.
Economics is still science: what 
about a life outside science? I 
think it was Lewis Wolpert who 
referred to a truth in the arts and 
humanities that is unconstrained 
by reality. I feel very comfortable 
with another truth that is 
constrained by reality and so I 
have found my niche in science. 
We all use the unconstrained 
truth either consciously or not 
when we imagine, for example, 
and I have great admiration for 
the people that use this other way 
of thinking more completely than 
I do. I enjoy their paintings, music 
and writing and their presence 
in my life but I wouldn’t want to 
fl y in an airplane, cure disease 
or grow crops according to their 
unconstrained truth. Of course, if 
I did abandon reality completely, 
I would be a second Charlie 
Parker.
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